Stay updated on Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous v3.6.4, indicating a version update of the study details page.
    Difference
    0.0%
    Check dated 2026-08-12T20:53:57.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.3 to v3.6.4, indicating a new release version without altering the displayed study details.
    Difference
    0.0%
    Check dated 2026-07-22T15:57:19.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Added a new PubMed publication entry for Shitara et al. on first-line zolbetuximab plus mFOLFOX6 and nivolumab in unresectable CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma. The citation shows Nat Med 2026 Jun;32(6):2182-2190 with an Epub date of 2026 Mar 16, replacing the earlier Online ahead of print note.
    Difference
    0.0%
    Check dated 2026-07-15T13:23:06.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision tag updated to v3.6.3, replacing the previous v3.6.0 on the page. This indicates a new site revision without altering study details.
    Difference
    0.0%
    Check dated 2026-07-01T10:17:53.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The study milestone dates were updated to Primary Completion: 2026-12-31 and Study Completion: 2027-11-30, with the last update posted on 2026-06-18, reflecting a refreshed timeline.
    Difference
    0.2%
    Check dated 2026-06-24T05:34:48.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Recruitment messaging now shows 'No longer looking for participants', the treatment label is standardized to 'Intervention/Treatment' (replacing 'Intervention / Treatment'), several help/navigation links were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision badge updates from v3.5.4 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-09T20:12:59.000Z thumbnail image

Stay in the know with updates to Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zolbetuximab in CLDN18.2+ Gastric Cancer Clinical Trial page.